The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
SandboxAQ is a company that many pharma and biotech professionals will be keeping an extremely close eye on in the coming years. Having SandboxAQ emerged as an independent company following spin-off ...
In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular pathways. However, traditional single-cell ...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.
Biologists from the University of York (UK) have discovered enzymes that catalyze the biosynthesis of alkaloids in a number ...
AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom ...
The global antibody discovery market, valued at USD 11.15 billion in 2025, is expected to surge to USD 35.35 billion by 2035, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results